////// Science for a better life Global Breadcrumb Home Investors Vision & Strategy Investing in the science behind what’s yet to come A business built to address evolving needs At Bayer, the work we do changes lives. We’re pursuing Science for a Better Life—not only for our stakeholders, but to benefit everyone. Our vision “Health for all, Hunger for none” articulates what we strive for. Our mission and development strategy are one in the same. Our research addresses the trends we are all facing in the coming decades—namely supporting an aging, growing global population by providing food and healthcare to all, while also using fewer resources and fighting climate change. By finding answers to these ongoing and evolving issues, we’re finding solutions for the many new challenges yet to come. We’re cultivating our ongoing legacy of innovation and our relentless pursuit of sustainability, to make meaningful advancements in Consumer Health, Pharmaceuticals, and Crop Science. DISCOVERING The Bio Revolution LEARN MORE ADVANCING Health Ownership LEARN MORE ADDRESSING Growing Healthcare Demand LEARN MORE EXPLORING The Future of Agriculture LEARN MORE Investment Case BAYER GROUP A Global Leader in Health & Nutrition READ MORE CROP SCIENCE Shaping the Future of Agriculture READ MORE Driving the cutting edge of Consumer Health More and more, people are taking charge of their health and self-care. Thanks to our ongoing innovation and investment in digitalization, we are well positioned to leverage new business opportunities developing from the growing consumer health market. To maximize our impact, we adopted a new operational model in 2019 that better enables us to provide customers with the products, services, and information they need to improve their quality of life by taking greater responsibility for their daily health. We’re accelerating organic growth across attractive categories, geographies, channels and brands and strive to transfer prescriptions and active ingredients to nonprescription status to heighten our consumer-and customer-centric approach. Forging new paths in Pharmaceuticals At Pharmaceuticals, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. Our R&D focuses on promising trends with great potential for improving patient well-being in therapeutic areas with a high medical need. With our innovations, we strive to enable people from all age groups “to be and do what they value throughout their lives” while aging actively and healthily. We want people to be able to share in medical progress, regardless of their income or background. To advance pharmaceutical innovation for patients and consumers while supporting access, we are collaborating with a number of partners. We will couple our scientific offering by embracing new opportunities in data science and digital technology to help us bring innovative therapies to patients and transform the way health care is delivered. Harnessing the power of Crop Science With a leading portfolio in corn, soybeans, cereal and horticulture, we are the largest integrated player in the agriculture industry. Our four-pronged strategy of innovation, digitalization, operational excellence and sustainability enables us to continually set and surpass new industry standards to deliver tailored solutions to farmers around the world that shape the future of agriculture. Leveraging our unsurpassed R&D platforms, our researchers deliver higher-performing seed varieties, biotech traits, chemical and biological crop protection products, and digital tools to pursue more sustainable models for accomplishing more through agriculture while also protecting our environment. Every investment in innovation is an investment in sustainability Our goals are ambitious—and achievable. We firmly believe that scientific discovery is the key to building a sustainable future, for our company, humanity, and our planet. As such, we are strategically investing to improve existing technologies, discover sustainable solutions, and pioneer new possibilities for all of us. We are deeply focused on operational excellence and disciplined capital allocation, which help ensure that our efforts generate the maximum positive impact. Well positioned in attractive markets Because innovation is the heart of everything we do, Bayer operates as a global leader in consumer health, pharmaceuticals, and Crop Science. Society will always need new solutions to harness evolving challenges and opportunities. Through strategic investments in our innovation pipeline, we’re constantly driving new possibilities for our business— and our world. Discover More Investor Resources INNOVATION Creating Value for Our Customers LEARN MORE SUSTAINABILITY & GOVERNANCE Making the Right Decisions, Responsibly LEARN MORE CONTACT IR TEAM Get In Touch With Us LEARN MORE NEWSLETTER Subscribe To Our Latest Investor News LEARN MORE Last Updated: Tuesday, November 23, 2021 Our Business Pharmaceuticals Consumer Health Crop Science Our Products Bayer Worldwide Magazines & Reports News & Stories Annual Report Quarterly Report More Publications Stay Tuned Job Postings Latest News Newsletter Bayer Share Price Get in Touch Do you have any queries or comments? GLOBAL FORM REPORT A SIDE EFFECT Follow Us Copyright © Bayer AG Conditions of Use Privacy Statement Cookie Settings Imprint Sitemap Usage of Cookies We would like to use optional cookies to better understand your use of this website, to improve our website and to share information with our advertising partners. Detailed information about the use of strictly necessary cookies, which are essential to browse this website, and optional cookies, which you can reject or accept below, and how you can manage or withdraw your consent at any time can be found in our Privacy Statement. COOKIE SETTINGS REJECT COOKIES ACCEPT COOKIES